This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

GAT-DCT-Discordance Due to Corneal Properties

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University of Zurich
ClinicalTrials.gov Identifier:
NCT01474070
First received: November 3, 2011
Last updated: October 17, 2016
Last verified: October 2016
  Purpose
IOP is measured with two devices (Dynamic Contour Tonometry (DCT) and Goldmann applanation tonometry (GAT)).

Condition Intervention Phase
Glaucoma Device: Intraocular Pressure Measurement Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Influence of Discordant Intraocular Eye Pressure Readings Taken by Dynamic Contour Tonometry and Goldmann Applanation Tonometry

Resource links provided by NLM:


Further study details as provided by University of Zurich:

Primary Outcome Measures:
  • Intraocular pressure (IOP) [ Time Frame: IOP is measured at the only study visit ]
    IOP is measured with goldman-applanation tonometer and dynamic-contour-tonometer at the only study visit (V0)


Secondary Outcome Measures:
  • Demographical and clinical data [ Time Frame: study visit V0 ]
    Age, axial length of the eye, central corneal thickness


Enrollment: 112
Study Start Date: November 2011
Study Completion Date: October 2016
Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: Intraocular Pressure Measurement
    Intraocular pressure is measured with GAT and with DCT
    Other Names:
    • Goldmann Applanation Tonometry (GAT)
    • Dynamic Contour Tonometry (DCT)
Detailed Description:

DCT reading will be compared to a corrected GAT reading by the formula of Elsheikh, Alhasso and Pye.

  • Trial with medical device
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
glaucoma patients
Criteria

Inclusion criteria:

  • clinical diagnosis of glaucoma

Exclusion criteria:

  • other optic neuropathy other then glaucoma
  • age<18
  • corneal surgery
  • use of contact lenses
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01474070

Locations
Switzerland
University Hospital Zurich, Ophthalmic Clinic
Zurich, ZH, Switzerland, 8091
Sponsors and Collaborators
University of Zurich
Investigators
Principal Investigator: Christoph Kniestedt, MD University Hospital Zurich, Ophthalmic Clinic
  More Information

Responsible Party: University of Zurich
ClinicalTrials.gov Identifier: NCT01474070     History of Changes
Other Study ID Numbers: GAT-DCT-Vergleich
Study First Received: November 3, 2011
Last Updated: October 17, 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by University of Zurich:
Glaucoma
Goldmann Tonometry
Dynamic Contour Tonometry

Additional relevant MeSH terms:
Glaucoma
Ocular Hypertension
Eye Diseases

ClinicalTrials.gov processed this record on July 24, 2017